Rebecca Gillingham
Psychiatric/Mental Health · Saratoga Springs, NYNPI 1386134260
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 399 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,626 and has fallen 59.9% since, to $1,455 in 2025. Among psychiatric/mental health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 399 payments — averaging $24.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$2K
- Axsome Therapeutics, Inc.$968
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$654
- Teva Pharmaceuticals USA, Inc.$527
- Otsuka America Pharmaceutical, Inc.$486
- plus $3K from 16 others
What the payments were for
- Food & beverage$9,54599%
- Education$751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 62 | $2,095 |
| AbbVie | 79 | $1,778 |
| Axsome Therapeutics, Inc. | 51 | $968 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $654 |
| Teva Pharmaceuticals USA, Inc. | 19 | $527 |
| Otsuka America Pharmaceutical, Inc. | 11 | $486 |
| Alkermes, Inc. | 16 | $485 |
| Vanda Pharmaceuticals Inc. | 29 | $467 |
| Corium, LLC | 28 | $409 |
| Neurocrine Biosciences, Inc. | 11 | $301 |
| Lundbeck LLC | 15 | $282 |
| Supernus Pharmaceuticals, Inc. | 7 | $265 |
| Idorsia Pharmaceuticals US Inc | 11 | $262 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $157 |
| Novo Nordisk | 7 | $119 |
| Bausch Health US, LLC | 5 | $82 |
| Sunovion Pharmaceuticals Inc. | 6 | $77 |
| E.r. Squibb & Sons, L.L.C. | 3 | $76 |
| Ironshore Pharmaceuticals Inc. | 3 | $68 |
| Almatica Pharma LLC | 2 | $31 |
| OWP Pharmaceuticals, Inc. | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$688
- LYBALVI$440
- CAPLYTA$247
- Auvelity$241
- INVEGA SUSTENNA$235
- REXULTI$229
- QELBREE$125
- VRAYLAR$124
- QUVIVIQ$117
- INVEGA TRINZA$116
- AUSTEDO$116
- ABILIFY MAINTENA$104
How this compares
$9,620 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 13 | $111 |
| Lorazepam | 11 | $78 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Saratoga Springs
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
- Daniel BreeyearNiskayuna$149K
- Elijah StevensBinghamton$131K
- Kayanna JonasFar Rockaway$93K
- Alexis CrisafiFishkill$70K
- Vera ImperialeAlbany$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.